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Metastatic intraocular hemangiopericytoma in a dog
Abstract
A 10-year-old Labrador Retriever who had been undergoing therapy for a recurrent hemangiopericytoma of
the right flank presented to the Kansas State University Ophthalmology service for evaluation of a painful left
eye. Examination revealed secondary glaucoma and irreversible blindness of the affected eye and multifocal
chorioretinal lesions in the fellow eye. Therapeutic and diagnostic enucleation of the left eye was performed
and histopathologic examination demonstrated the presence of a presumed metastatic spindle cell sarcoma.
Further immunohistochemical staining confirmed the intraocular neoplasia to be metastatic spread from the
previously removed flank mass. Rapid progression in size and number of chorioretinal lesions in the right eye
was noted in the post-operative period until the patient was euthanized one month after surgery. This case
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A 10-year-old Labrador Retriever who had been undergoing therapy for a recurrent hemangiopericytoma of the right 
flank presented to the Kansas State University Ophthalmology service for evaluation of a painful left eye. Examination 
revealed secondary glaucoma and irreversible blindness of the affected eye and multifocal chorioretinal lesions in the 
fellow eye. Therapeutic and diagnostic enucleation of the left eye was performed and histopathologic examination 
demonstrated the presence of a presumed metastatic spindle cell sarcoma. Further immunohistochemical staining 
confirmed the intraocular neoplasia to be metastatic spread from the previously removed flank mass. Rapid 
progression in size and number of chorioretinal lesions in the right eye was noted in the post-operative period until 
the patient was euthanized one month after surgery. This case report is the first to document intraocular metastasis of 
hemangiopericytoma in a veterinary patient. 




Malignant tumors can originate throughout the body, 
yet despite the well vascularized nature of the uveal 
tract metastasis to the ocular tissues is not a common 
occurrence. Lymphoma is the most common of those 
tumors which have been noted to spread to the eye 
(Hendrix, 2013). Less commonly documented 
intraocular metastatic neoplasms include melanoma, 
hemangiosarcoma, malignant histiocytosis, 
adenocarcinoma, osteosarcoma, transitional cell 
carcinoma, and others (Szymanski, 1972; Schmidt, 
1981; Render et al., 1982; Szymanski et al., 1984; 
Habin and Elsa, 1995; Esson et al., 2007; Naranjo et al., 
2007; Mowat et al., 2012).  
Patients with metastatic ocular neoplasia may present 
with systemic signs attributable to the disease or may 
only have observable ophthalmic signs. Although 
possibly asymmetric in presentation, metastatic 
neoplasia is more likely to affect both eyes than primary 
tumors (Hendrix, 2013).  
This case report is the first to describe metastatic spread 
of hemangiopericytoma to both eyes of a dog. 
Case Details 
A 10 year old, male neutered Labrador Retriever was 
referred to the ophthalmology service at Kansas State 
University’s College of Veterinary Medicine due to left 
sided ocular discomfort, diffuse corneal edema, and 
possible vision loss. The patient was undergoing 
radiation therapy for a recurrent subcutaneous right 
flank mass, diagnosed as a hemangiopericytoma.  
The original mass was removed from the right hip 18 
months prior to presentation and on histopathology 
presented as a poorly delineated and infiltrative 
neoplastic tissue, partially effacing the superficial and 
deep dermis and composed of spindled to round cells 
with small amounts of pale or eosinophilic cytoplasm, 
indistinct cell borders and bland vesicular nuclei, 
arranged in streams and bundles forming variably 
ectatic or compressed, thin walled branching vascular 
channels.  
Despite multiple surgical resections and complete 
excision according to histopathologic evaluation, the 
mass continued to recur subcutaneously in the right 
flank region. Based on the recurrence of the mass in the 
face of multiple resections, radiation therapy following 
excision and skin grafting was performed. Routine 
examination 4 months after radiation therapy showed a 
new subcutaneous mass in the right flank and multiple 
pulmonary nodules visible on computerized 
tomography (CT) scan. Two weeks after diagnosis of 
the pulmonary nodules the ocular signs became 
evident.  
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Ophthalmic examination revealed slight 
blepharospasm and epiphora of the left eye (OS) along 
with an elevated third eyelid. No pain or significant 
adnexal abnormalities were noted in the right eye (OD) 
except for a single distichia dorsally. Menace response 
and dazzle reflexes were present OD but were both 
absent OS. Direct pupillary light response was present 
OD and absent OS. A consensual pupillary light 
response was not noted in either eye. Severe 
conjunctival hyperemia and moderate episcleral 
injection were noted OS. Fluorescein staining was 
negative in both eyes for epithelial defects. Intraocular 
pressures measured by rebound tonometry (TonoVet®; 
Jorgensen Labs, Loveland, CO) were 6 and 60 mmHg 
OD and OS respectively.  
On biomicroscopic examination (Kowa SL-15; Kowa 
Company, Tokyo, Japan) the cornea of the OS had 
moderate diffuse corneal edema making it difficult to 
visualize intraocular structures in detail, however, a 
dyscoric and relatively miotic pupil were detectable as 
well as a diffusely swollen and reddened iris profile. 
Extensive posterior synechia and iris swelling 
contributed to the dyscoria OS and structures posterior 
to the pupil could not be visualized. Examination of the 
cornea and anterior segment of the OD was 
unremarkable. Nuclear sclerosis was present OD as 
well as a ventromedial pinpoint anterior cortical 
incipient cataract and mild anterior vitreal syneresis. 
Upon indirect ophthalmoscopic examination (Vantage 
Plus Wireless, Keeler Instrument Inc, Bromall, PA) of 
the OD, multifocal lesions in the tapetal fundus were 
noted and photodocumented (RetCam Shuttle; Clarity 




Fig. 1. Presence of chorioretinal lesions in the tapetal fundus 
OD noted on initial presentation. Images represent central 
view (A) and a view angled to highlight the largest 
chorioretinal lesion (B). Multifocal pink lesions are noted 
throughout the tapetal fundus arising from the termination of 
retinal vessels representing metastatic spread of the 
hemangiopericytoma. Images obtained with the RetCam 
Shuttle. 
 
The largest lesion was raised, pale pink in color, one 
optic nerve head in diameter and located dorsomedial 
to the optic disc arising at the termination of a retinal 
vessel. Other smaller lesions appeared multifocally 
throughout the tapetal fundus as pinpoint reddish-pink 
colored lesions near the termination of retinal vessels, 
some of which could not be differentiated from retinal 
hemorrhages. Based on the clinical evidence, 
secondary glaucoma of the OS was diagnosed as well 
as suspected chorioretinal metastatic disease lesions 
OD. 
Enucleation of the painful globe OS was recommended 
in order to provide comfort as well as diagnostic benefit 
through histopathology. Preoperative blood work was 
obtained and no significant abnormalities were noted. 
On physical examination, the patient was bright, alert 
and responsive as well as mildly overweight. No 
significant abnormalities were detected on thoracic 
auscultation or complete physical examination other 
than mild dental calculus, bilateral coxofemoral pain, 
and a 2 x 3 x 2 cm right flank subcutaneous mass. Fine 
needle aspirates of the subcutaneous mass performed 
five weeks prior revealed a spindle cell population with 
features of malignancy suggestive of a sarcoma. The 
left globe was removed using a transconjunctival 
approach and the patient recovered uneventfully. After 
removal, the globe was immersion fixed in 10% neutral 
buffered formalin and submitted to the Comparative 
Ocular Pathology Laboratory of Wisconsin for 
histopathologic evaluation.  
Histopathology revealed a population of neoplastic 
spindle cells arranged in streams and bundles carpeting 
the surfaces of the iris and ciliary body, infiltrating and 
expanding the tapetal choroid and multifocally 
invading the choroidal vessels (Fig. 2A and 2B). The 
cells presented indistinct cell borders, small amounts of 
eosinophilic cytoplasm and oval to elongated nuclei 
with usually a large and central magenta nucleolus. 
Mitotic figures were common averaging 6 per high 
power field and cellular pleomorphism was marked 
with multiple karyomegalic cells. Neoplastic cells were 
also found to extend within scleral blood vessels (Fig. 
2C). Notable secondary ocular lesions were posterior 
synechia, retinal detachment and secondary glaucoma, 
characterized by loss of ganglion cells and gliosis of the 
optic nerve head. The pattern of distribution of the 
neoplastic cells within the globe, with cells carpeting 
ocular surfaces and multifocally infiltrating the uveal 
tissue along with the presence of neoplastic cells in 
blood vessels was strongly suggestive of a metastatic 
disease. Sections of the previously excised flank 
hemangiopericytoma and the left globe were selected 
for immunohistochemistry to determine if the 
intraocular mass was metastatic or a separate neoplastic 
process. Sections were stained using the following 
antibodies: Skeletal muscle actin (mouse anti-
sarcomeric actin, clone alpha-Sr-1, 1:150 dilution, 
Dako, Carpinteria, CA), Vimentin  (mouse anti-
vimentin, clone V9, 1:200, Dako), Alpha-smooth 
muscle actin (mouse anti–alpha smooth muscle actin, 
clone 1A4, 1:1000, Dako), S-100 (rabbit anti–S100 
protein, 1:2500, Dako), CD31 (mouse anti-CD31, 1:40, 
Dako) and CD34 (mouse anti-CD34, 1:50, Dako).  
http://www.openveterinaryjournal.com 






Fig. 2. (A): Metastatic spindle cell sarcoma. Subgross 
photograph. Note the carpet of neoplastic cells in the choroid 
(arrow) and in the ciliary body (*). Hematoxylin and eosin 
(H&E). (B): Tumor in the choroid. Higher magnification of 
the neoplastic cells near the arrow in Fig. 2A. Cells infiltrate 
the tapetum (*) and surround choroidal vessels (arrow). 
(H&E) (Bar = 100 m). (C): Tumor in the scleral vessels. 
Higher magnification of the square in Fig. 2A. Cells surround 
and infiltrate scleral vessels (arrow). (H&E). (Bar = 100 m). 
The results of the immunohistochemical staining 
showed perfect alignment in staining patterns in that the 
two separate masses were vimentin, alpha-smooth 
muscle actin and CD34 positive, while negative for 
skeletal muscle actin, S-100 and CD31 (Fig. 3). 
Together with the microscopic features of the flank 
mass (fusiform cells forming irregular vascular 
channels with a staghorn pattern) the 
immunohistochemical staining pattern confirmed the 
diagnosis of hemangioperycitoma  and a metastatic 
spread of the right flank neoplasm to the eye in this case 
(Avallone et al., 2007).  
The patient returned two weeks after surgery for routine 
enucleation site suture removal. Upon exam of the OD 
fluorescein staining was negative, the intraocular 
pressure was 5 mmHg, the direct pupillary light reflex 
was positive and a menace response was present. 
Despite the lower intraocular pressure, there was no 
evidence of blepharospasm, epiphora, conjunctival 
hyperemia, miosis, or aqueous flare on her exam.  
No changes in the lenticular opacities were observed, 
however, fundic examination revealed that the 
chorioretinal lesions had progressed significantly in 
size and number throughout the tapetal fundus (Fig. 4). 
Perilesional retinal detachments were identified around 
the larger pink colored lesions. Despite disease 
progression, the patient remained comfortable and 
visual. Prophylactic topical anti-inflammatory and 
topical anti-glaucoma therapy were discussed with the 
owner given the previous progression OD and previous 
sequelae OS but were declined. Five days after suture 
removal the patient presented for acute blepharospasm 
and epiphora of the OD. Fluorescein staining was 
negative and the intraocular pressure was 6 mmHg. A 
small fibrin clot was noted on the anterior surface of the 
lens capsule axially along with a trace amount of 
aqueous flare. No significant progression of the 
chorioretinal lesions was detected. The patient was 
started on 1% topical ophthalmic prednisolone acetate 
suspension (Falcon Pharmaceuticals, Hűnenberg, 
Switzerland) every 8 hours as well as 2.2 mg/kg of oral 
carprofen (Rimadyl; Pfizer Inc, New York, NY) every 
twelve hours. In addition, despite a low but seemingly 
normal intraocular pressure, topical 2% dorzolamide 
(Dorzolamide HCL 2% ophthalmic solution; Hi-Tech 
Pharmacal Co, Amityville, NY) solution was instituted 
every 8 hours OD given previous progression to 
secondary glaucoma OS. A recheck was scheduled for 
1 week. Three days later the patient presented on 
emergency for difficulty urinating and a gallop rhythm 
was ausculted on physical exam. Radiographs showed 
multiple small cystic and urethral calculi, slight 
enlargement of the previously noted pulmonary 
nodules, and right sided cardiac enlargement.  
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Fig. 3. Immunohistochemical staining of both the original right flank/limb hemangiopericytoma and the left eye metastasis. Both 




Fig. 4. Image of right tapetal fundus two weeks after initial 
presentation. The presence of numerous large pink/red 
colored lesions throughout tapetal fundus present near retinal 
vessel terminations showing significant progression of 
chorioretinal lesions. Perilesional retinal elevations are seen 
around each foci of metastasis and appear as halos of reduced 
reflectivity. Image obtained with the RetCam Shuttle. 
 
On echocardiogram, a 5x3 cm heteroechoic mass was 
noted arising from the right atrium and extending into 
the auricle with moderate pericardial effusion but no 
cardiac tamponade. Due to the extensive nature and 
poor prognosis, the patient had a urethral catheter 
placed and was discharged for palliative care by the 
owner and referring veterinarian. One week later the 
patient was euthanized. A postmortem examination was 
not performed and no tissues were available for 
evaluation.             
Discussion 
Perivascular wall tumor is a term used to describe the 
grouping of soft tissue sarcomas which have origins in 
the structural and supportive cells of blood vessels 
(Avallone et al., 2007).   
Hemangiopericytoma refers to a sub-category of 
perivascular wall tumors and is a rare vascular tumor 
that is thought to arise from mesenchymal cells which 
coat capillaries and post capillary venules, known as 
pericytes of Zimmerman. This type of tumor was first 
described by Stout and Murray (1942).  
Since the initial manuscript there have been numerous 
reports documenting this tumor in humans and various 
veterinary species (Mulligan, 1955; Enzinger and 
Smith, 1976; Richardson et al., 1983; Boniuk et al., 
1985; Fossum et al., 1988; Graves et al., 1988; Mitarai 
et al., 1998; Beltran et al., 2001; McCaw et al., 2001; 
Serena et al., 2006; Silva et al., 2014).  
Most commonly, hemangiopericytoma is reported in 
dogs, of which it accounts for around 3-4% of all 
cutaneous neoplasia (Graves et al., 1988). The tumors 
are reported to be well circumscribed initially with a 
pseudocapsule covering the mass (Henderson and 
Farrow, 1978; Sujatha et al., 1994) and attached to 
deeper structures with freely movable skin over the 
surface (Caniatti et al., 2001). If the pseudocapsule is 
breached during surgery or incomplete excision is 
noted, extensive local regrowth and metastasis can be 
seen (Shimura et al., 2001).     
Proper diagnosis of hemangiopericytomas can be 
challenging from a histopathologic standpoint and 
recent investigations show that many previous cases 
diagnosed as such may actually represent one of a 
spectrum of perivascular wall tumors (Avallone et al., 
2007; Palmieri et al., 2013). The originally described 
microscopic pattern of a hemangiopericytoma 
consisted of concentric layers of spindle cells arranged 
http://www.openveterinaryjournal.com 




around a central vessel which was devoid of 
erythrocytes, known as a “fingerprint, staghorn, or 
onion skin pattern” (Perez et al., 1996). This pattern is 
often lacking and non-specific as it can even be found 
in other types of vascularized soft-tissue neoplasms 
(Pantekoek and Schiefer, 1975).  
Definitive diagnosis requires immunohistochemical 
staining or electron microscopy to differentiate 
hemangiopericytoma from other soft tissue sarcomas 
(Avallone et al., 2007; Palmieri et al., 2013). Previous 
reports have tried to elucidate the immunoreactivity 
patterns to aide differentiation. Hemangiopericytoma 
cells stain positive for vimentin and CD 34, owing to 
their mesenchymal and endothelial cell derivation 
respectively (Perez et al., 1996; Middleton et al., 1998). 
Staining for S-100 and CD 31 are negative, proving the 
neoplasms are not of peripheral nerve, melanocyte, 
granular cell, macrophage, or monocyte origin 
(Middleton et al., 1998). Staining for muscle actins can 
be variable depending on their location and if 
describing human or canine hemangiopericytoma. 
While canine hemangiopericytomas express muscle 
actins, human hemangiopericytomas are lacking this 
trait. This means that the human neoplasia counterpart 
either loses the expression during differentiation, or the 
cell of origin is not a true pericyte (Porter et al., 1991; 
Perez et al., 1996).  
In dogs, the expression or not of α-smooth muscle actin 
depends on whether the tumor formed from capillary or 
arteriolar and venular pericytes (Herman and D'amore, 
1985; Schürch et al., 1987). Alpha-smooth muscle actin 
is expressed in hemangiopericytomas that arise from 
arteriolar or venular pericytes and non-smooth muscle 
actin isoforms are derived from those of capillary origin 
(Herman and D'amore, 1985). This explains the 
variable staining noted in hemangiopericytomas with 
regard to α-smooth muscle actin. In our case, both the 
original flank mass and the intraocular metastasis 
lesions were in perfect alignment with regard to 
reported hemangiopericytoma immunohistochemical 
staining patterns, confirming the diagnosis.     
Hemangiopericytomas tend to develop on distal 
extremities of older dogs and have a slow growth rate 
(Mulligan, 1955; Graves et al., 1988; Mazzei et al., 
2002).  
In humans, common locations for development of 
hemangiopericytoma are the thigh and pelvic 
retroperitoneal regions (Enzinger and Smith, 1976; Lee 
et al., 2003). Average age at the time masses are 
observed in dogs is around 10 years, with a range of 2-
14 years (Graves et al., 1988; Caniatti et al., 2001; 
Namazi et al., 2014).  
The frequency of metastasis is presumed to be low 
based on available cases, but local recurrence is high 
due to the infiltrative nature of the mass (Yost and 
Jones, 1958; Handharyani et al., 1999). Recurrence 
rates after excision approximate 40% even if all grossly 
visible tumor has been removed (Graves et al., 1988). 
A statistically significant difference has not been shown 
between simple excision, excision with orthovoltage 
radiation, and excision with subsequent photodynamic 
therapy (Graves et al., 1988; McCaw et al., 2001).  
Seven previous canine cases have been recognized to 
have metastasized, and of those the lungs and lymph 
nodes were sites of spread (Handharyani et al., 1999; 
Silva et al., 2014). In humans, the rate of metastasis has 
been reported to be as high as 50%, with spread to the 
lungs, liver, and bones occurring most frequently 
(Johnson, 1976). The reason for the low rate of 
metastasis in dogs as compared to humans has not been 
determined.      
In humans, hemangiopericytoma is very rarely found in 
or around the eye with the majority of cases being 
retrobulbar in origin (Henderson and Farrow, 1978; 
Karcioglu et al., 1997; Lee et al., 2003; Manjandavida 
et al., 2013). Other reported locations include the 
lacrimal sac, optic nerve, conjunctiva, and eyelids 
(Boniuk et al., 1985; Grossniklaus et al., 1986; Sujatha 
et al., 1994; Charles et al., 1998; Parmar and Rose, 
2003; Schwent et al., 2007). There have been only 5 
cases of intraocular hemangiopericytoma reported to 
date (Papale et al., 1983; Gieser et al., 1988; Brown et 
al., 1991; Toth et al., 1996; Shimura et al., 2001). Of 
these most were considered primary lesions, however, 
metastatic spread from another primary location was 
not completely ruled out.  
In veterinary patients, the reported incidence of ocular 
hemangiopericytoma is also low with only 2 reported 
cases. The first was a presumed orbital 
hemangiopericytoma in a seven year old mixed-breed 
dog presenting with progressive unilateral 
exophthalmos (Beltran et al., 2001). The tumor was 
diagnosed by histopathologic evaluation after removal, 
however immunohistochemical staining was not 
performed to differentiate from peripheral nerve sheath 
tumors or other soft tissue sarcomas. The other ocular 
hemangiopericytoma was documented in an eyelid of a 
fourteen year old Arabian horse (Serena et al., 2006). 
The mass had been present for two years but then 
rapidly increased in size, prompting exam and removal. 
The diagnosis was confirmed through 
immunohistochemical staining of excised tissue. One 
year after removal, no recurrence of the mass or spread 
was noted. 
To the authors’ knowledge, the case reported here is the 
first to document presumed intraocular metastatic 
spread of a perivascular wall tumor in a veterinary 
patient.  
Unlike previously reported ocular manifestations, the 
hemangiopericytoma in our case progressed rapidly. 
The findings of a right sided heart mass and the 
suspected pulmonary metastatic lesions during the 
http://www.openveterinaryjournal.com 




course of diagnosis and therapy are interesting but the 
significance is not known as diagnostic samples were 
never obtained.  
In addition, a post mortem examination was not 
performed and so any attempt to correlate these to the 
primary hemangiopericytoma would be unfounded and 
only the ocular metastasis lesions were confirmed. 
Intraocular metastasis may represent a late stage of 
progression with hemangiopericytoma or could signal 
a more aggressive tumor as evidenced by the very short 
survival time of this patient after recognized intraocular 
spread.                
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